PainChek Limited (ASX:PCK – Get Free Report) insider John Murray acquired 1,133,144 shares of the company’s stock in a transaction dated Friday, September 26th. The stock was acquired at an average cost of A$0.05 per share, for a total transaction of A$61,189.78. PainChek Price PerformanceThe company has a market cap of $50.62 million, a PE ratio of -5.23 and a beta of 0.74. Get PainChek alerts:About PainChek(Get Free Report)See AlsoDevelopment and commercialisation of mobile medical applications that are intended to provide pain assessment for individuals who are unable to communicate with their carers. Receive News & Ratings for PainChek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PainChek and related companies with MarketBeat.com's FREE daily email newsletter.